Institut für Experimentelle und Klinische Pharmakologie und Toxikologie


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Pseudo-Worsening of Kidney Function (2025) Fromm M, Sponfeldner M, Dörje F, Geßner K, Dürr P, Cuba L, Schwanfelder J Journal article, Letter Clinical–pharmaceutical assessment of medication CDSS alerts: content appropriateness and patient relevance in clinical practice (2025) Bauer J, Busse M, Koch S, Schmid M, Sommer J, Fromm M, Dörje F Journal article Physicians' and pharmacists' perspective on clarity and clinical relevance of absolute contraindications in “Summaries of Product Characteristics” (2025) Andrikyan W, Sponfeldner M, Jung-Poppe L, Dürr P, Straubmeier MI, Schuster AK, Weisbach L, et al. Journal article Meis transcription factors regulate cardiac conduction system development and adult function (2025) Muñoz-Martín N, Simon-Chica A, Díaz-Díaz C, Cadenas V, Temiño S, Esteban I, Ludwig A, et al. Journal article Therapeutic drug monitoring of imatinib in paediatric chronic myeloid leukaemia: Data from a real-world setting (2025) Suttorp M, Sembill S, Lensker P, Hildebrand V, Schirmer E, Karow A, Krumbholz M, et al. Journal article fMRI data acquisition and analysis for task-free, anesthetized rats (2025) Vrooman RM, van den Berg M, Desrosiers-Gregoire G, van Engelenburg WA, Galteau ME, Lee SH, Veltien A, et al. Journal article An untargeted metabolomics approach to evaluate enzymatically deconjugated steroids and intact steroid conjugates in urine as diagnostic biomarkers for adrenal tumors (2025) Vogg N, North E, Geßner A, Fels F, Heinrich M, Kroiss M, Kurlbaum M, et al. Journal article Factors Associated With Persisting Olfactory Dysfunction After COVID-19 (2025) Prem B, Liu DT, Boehme K, Maurer MT, Renner B, Mueller CA Journal article Disease-associated brain activation predicts clinical response to TNF inhibition in rheumatoid arthritis (PreCePra): a randomised, multicentre, double-blind, placebo-controlled phase 3 study (2025) Heß A, Tascilar K, Schenker H, Konerth L, Schönau V, Sergeeva M, Kreitz S, et al. Journal article Implications for medication safety and adherence in dermato-oncology: The AMBORA care program for oral antitumor therapeutics (2025) Cuba L, Dörje F, Kramer R, Dürr P, Erdmann M, Fromm M, Berking C, Geßner K Journal article